Evaluation of Retreatment and Case Fatality Rates for Calves Treated with Antimicrobials and Ancillary Flunixin Meglumine for BRD Complex

Authors

  • E. D. Linsenmeyer Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506
  • D. U. Thomson Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506
  • J. T. Fox Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506
  • N. N. Lindberg Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506

DOI:

https://doi.org/10.21423/aabppro20094302

Keywords:

respiratory disease, BRD, feedyard, calves, flunixin meglumine, NSAID, ancillary use

Abstract

Calves in a feed yard setting are commonly treated for respiratory disease (BRD). Often there are ancillary drugs used in addition to a primary antimicrobial. One of the ancillary treatments used is flunixin meglumine. Flunixin meglumine is labeled as a non-steroidal anti-inflammatory drug with antipyretic activity. Calves treated with flunixin meglumine show decreased body temperature in 24 hours. There is little data showing the effects of ancillary use on retreatment and case fatality rates. The objective of this trial was to evaluate repull rates and case fatality rates on BRD complex treated with or without ancillary flunixin meglumine.

Cover image of the 42nd Conference Proceedings: Cattle grazing in a spring field along the horizon. In the foreground, one brown cow with a triangle marking and ear tags is posing. Yellow background.

Downloads

Published

2009-09-10

Issue

2009

Section

Research Summaries 1